Life Healthcare has made changes to its leadership structure after the disposal of the Alliance Medical Group (AMG), with the executive committees of Life Healthcare and AMG being combined and reconstituted.
The reconstituted executive committee will continue to be led by Peter Wharton-Hood as the CEO, however, reports BusinessLIVE.
Pieter van der Westhuizen will remain as CFO, but will also assume responsibility for the IT and cyber portfolios.
Adam Pyle moves from the role of CEO Southern Africa into the new position of chief strategy and growth officer where he will take responsibility for the critical focus on Southern Africa growth opportunities. These include renal dialysis, diagnostic imaging, nuclear medicine and oncology.
Pyle’s portfolio will also include stakeholder relations, new products, marketing and communication as well as investor relations. He will also co-ordinate Life Healthcare’s strategy.
The chief strategy and growth officer is a critical role in delivering on the company's future growth strategy, it said.
Craig Koekemoer, who previously held the position of business operations executive SA, will take on the new role of COO.
Life Healthcare recently distributed the proceeds of the sale of its interest in UK-based AMG to shareholders by way of a special dividend of R6 per share.
BusinessLIVE article – Life Healthcare shakes up its executive (Restricted access)
See more from MedicalBrief archives:
Life Healthcare considers offers for European subsidiary
Life Healthcare diversifying to counter global regulatory pressures
Private hospitals change focus as belts tighten
Radiological Society challenges legality of Life Healthcare expansion